Explore more publications!
US Daily Ledger
Got News to Share?

Press Releases

Criminal Illegal Alien Kills 8-Year-Old Girl in Suspected Drunk Driving Crash in Newsom’s Sanctuary California
December 6, 2025

Criminal Illegal Alien Kills 8-Year-Old Girl in Suspected Drunk Driving Crash in Newsom’s Sanctuary California

Gov't Institution Department of Homeland Security - Washington D.C.
Owner: American Government

Department of Homeland Security - Washington, D.C.

Gov't Institution
Owned By American Government
Year Founded 2002
Website www.dhs.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, District of Columbia, Washington, D.C.
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Despite Media’s Claims, ICE Continues to Arrest the Worst of Worst Criminal Illegal Aliens Including Murderers, Arsonists, and Child Sexual Predators
December 6, 2025

Despite Media’s Claims, ICE Continues to Arrest the Worst of Worst Criminal Illegal Aliens Including Murderers, Arsonists, and Child Sexual Predators

Gov't Institution Department of Homeland Security - Washington D.C.
Owner: American Government

Department of Homeland Security - Washington, D.C.

Gov't Institution
Owned By American Government
Year Founded 2002
Website www.dhs.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, District of Columbia, Washington, D.C.
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human…
December 6, 2025

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human…

Indeterminate GlobeNewswire, Inc.
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH)…
December 6, 2025

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH)…

Indeterminate GlobeNewswire, Inc.
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
December 6, 2025

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire, Inc.
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 6, 2025

Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)

Indeterminate GlobeNewswire, Inc.
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting
December 6, 2025

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire, Inc.
Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
December 6, 2025

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

Indeterminate GlobeNewswire, Inc.
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
December 6, 2025

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire, Inc.
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
December 6, 2025

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire, Inc.
U.S. Businesses Turn to Cloud Managed Services for Scalability and Operational Agility
December 5, 2025

U.S. Businesses Turn to Cloud Managed Services for Scalability and Operational Agility

Neutral EIN Presswire
U.S. Businesses Benefit from Cloud Web Hosting Providers Driving Digital Success
December 5, 2025

U.S. Businesses Benefit from Cloud Web Hosting Providers Driving Digital Success

Neutral EIN Presswire
Cloud Web Hosting Providers Empower U.S. Companies to Scale Securely and Efficiently
December 5, 2025

Cloud Web Hosting Providers Empower U.S. Companies to Scale Securely and Efficiently

Neutral EIN Presswire
Managed Cloud IT Services Empower U.S. Businesses to Scale Securely and Drive Digital Growth
December 5, 2025

Managed Cloud IT Services Empower U.S. Businesses to Scale Securely and Drive Digital Growth

Neutral EIN Presswire
SummerMae Unveils Lycra® Maternity Underwear, Supporting U.S. Moms Through Full-Scenario Pregnancy Care
December 5, 2025

SummerMae Unveils Lycra® Maternity Underwear, Supporting U.S. Moms Through Full-Scenario Pregnancy Care

Indeterminate GlobeNewswire, Inc.
Cloud Web Hosting Providers Empower U.S. Businesses to Innovate and Grow Faster
December 5, 2025

Cloud Web Hosting Providers Empower U.S. Businesses to Innovate and Grow Faster

Neutral EIN Presswire
Managed Cloud Services Provider IBN Technologies Strengthens U.S. Firms’ Cloud Systems
December 5, 2025

Managed Cloud Services Provider IBN Technologies Strengthens U.S. Firms’ Cloud Systems

Neutral EIN Presswire
Sales Order Processing Automation Strengthens Supply Chain Efficiency Across U.S. Hospitals
December 5, 2025

Sales Order Processing Automation Strengthens Supply Chain Efficiency Across U.S. Hospitals

Neutral EIN Presswire
Dr. Hazem Afifi Launches Annual Scholarship to Support Future Healthcare Leaders Across the U.S.
December 5, 2025

Dr. Hazem Afifi Launches Annual Scholarship to Support Future Healthcare Leaders Across the U.S.

Neutral EIN Presswire
OneSolution Standardizes Ladder Safety Programs Amid U.S. Data Center Boom
December 5, 2025

OneSolution Standardizes Ladder Safety Programs Amid U.S. Data Center Boom

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions